Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.25 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:16 AM 03/11/15 All times are local (Market data is delayed by at least 15 minutes).

acuvax ltd (ACU) Snapshot

Open
--
Previous Close
A$0.25
Day High
--
Day Low
--
52 Week High
02/20/15 - A$0.29
52 Week Low
02/12/15 - A$0.16
Market Cap
35.9M
Average Volume 10 Days
0.0
EPS TTM
A$-0.10
Shares Outstanding
143.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACUVAX LTD (ACU)

Related News

No related news articles were found.

acuvax ltd (ACU) Related Businessweek News

No Related Businessweek News Found

acuvax ltd (ACU) Details

Acuvax Limited primarily researches and develops cancer therapies in Australia. It is also involved in the development of viruses and vaccines. The company is based in West Perth, Australia.

acuvax ltd (ACU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

acuvax ltd (ACU) Key Developments

Acuvax Limited, Special/Extraordinary Shareholders Meeting, Mar 12, 2015

Acuvax Limited, Special/Extraordinary Shareholders Meeting, Mar 12, 2015., at 10:30 W. Australia Standard Time. Location: Suite 4, 16 Ord St. Agenda: To approve second consolidation of capital; to change of nature and scale of activities; to approve future issue of Shares and Options; to approve issue of shares to Roland H Berzins and Associates (and/or their nominee) in Lieu of Directors fees; and to approval issue of shares to Fay Holdings Pty Ltd, Spartan Nominees Pty Ltd, Sealblue Investments Pty, AAG Management Pty Ltd, GCP Capital Pty Ltd, Screm Holdings Pty Ltd, Muries Lawyers, Hampton Court Partners, SilikonRok Pty Ltd; to approve Section 195; to change of name of company; to approve creation of New Class of Securities ­Performance Shares; to issue Consideration to Vendors (Unrelated Parties); to issue of Consideration to Related Party Vendor; and to approve issue of Shares to the creditors of Activistic Pty Ltd (and/ or their nominee) in Lieu of creditor payments.

Acuvax Limited, Annual General Meeting, Feb 09, 2015

Acuvax Limited, Annual General Meeting, Feb 09, 2015., at 10:00 W. Australia Standard Time. Location: Suite 4, 16 Ord Street. Agenda: To approve the ratification of prior placement; to consider consolidation of capital; to consider ratification of issue of First Convertible Note (Maxim Convertible Note 1); to consider approval of issue of Second Convertible Note (Maxim Convertible Note 2); to consider approval of placement of shares; and to consider approval of placement of options.

Acuvax Limited Announces Loan Facility Extension

Acuvax Limited announced that it is completing a funding arrangement with a private equity investor syndicate to provide additional working capital. The funds raised total $250,000 and under the terms of the facility, the loan is repayable 12 months from the date of issue and at a coupon rate of 12%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACU:AU A$0.25 AUD 0.00

ACU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACU.
View Industry Companies
 

Industry Analysis

ACU

Industry Average

Valuation ACU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 49.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACUVAX LTD, please visit www.acuvax.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.